Delivery Order SPE2DR25D9102-SPE2DR26FDDV5
Award Date 4/1/26
Potential Completion Date 4/22/26
Potential Value $12K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 13, 2026, for $11,771.46 to supply Nuplazid 34 mg capsules under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under the PPV-G GEN V, a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables...
- The Defense Logistics Agency issued a $3,923.82 delivery order to DMS Pharmaceutical Group Inc. on March 3, 2026, for Nuplazid 34 mg capsules under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. The delivery order is issued under the PPV-G GEN V, a Defense Logistics Agency single-award indefinite delivery contract with a $499.999 billion ceiling and ultimate completion date of...
- The Defense Logistics Agency issued a $11,771.46 delivery order to DMS Pharmaceutical Group Inc. on February 4, 2026, for Nuplazid 34 mg capsule 30-count units under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under the PPV-G GEN V, a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical...
- The Defense Logistics Agency issued a $3,923.82 delivery order to DMS Pharmaceutical Group Inc. on February 19, 2026, for Nuplazid 34 mg capsules under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under the PPV-G GEN V indefinite delivery contract, a Defense Logistics Agency pharmaceutical prime vendor program authorizing firm fixed-price delivery orders for branded and generic...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 12, 2026, for $11,771.46 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for supply of Nuplazid 34 mg capsules. DMS Pharmaceutical Group Inc. is a woman-owned small business. The parent contract, SPE2DR, is a single-award indefinite delivery contract with a $499.9 million ceiling and ultimate completion date of December 31, 2036, supporting pharmaceutical supply to...
- The Defense Logistics Agency issued a $3,923.82 delivery order to DMS Pharmaceutical Group Inc. on March 23, 2026, for Nuplazid 34 mg capsules under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, IL. The order is firm fixed price with an ultimate completion date of April 13, 2026. The delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 27, 2026, for Nuplazid 34 mg capsules with a ceiling value of $3,923.82. DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency single-award IDC authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 18, 2026, for Nuplazid 34 mg capsules, with a ceiling value of $3,923.82. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract that authorizes firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations worldwide. Place...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 9, 2026, with a ceiling value of $11,771.46 for supply of Nuplazid 34 mg capsule 30-count units, with ultimate completion by March 3, 2026. DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under the company's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) Indefinite Delivery Contract (SPE2DR), a single-award DLA pharmaceutical supply...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 24, 2026, for $3,923.82 in firm fixed-price pharmaceutical supply under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract. The order covers Nuplazid 34 mg capsule 30-count units for delivery to Park Ridge, Illinois, with an ultimate completion date of April 14, 2026. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler that holds a...